Understanding the dynamics of opioid substitution therapy retention: a qualitative analysis of injecting drug users in Chandigarh

Sukhbir Singh; Gaurav Gaur; Kumool Abbi; Nidhi Jaswal; Sandeep Mittal; Poonam Bakshi

doi:10.18203/2394-6040.ijcmph20254423

Authors

Sukhbir Singh Population Research Centre, Panjab University Chandigarh, India
Gaurav Gaur Centre for Social Work, Panjab University Chandigarh, India
Kumool Abbi Population Research Centre, Panjab University Chandigarh, India
Nidhi Jaswal Arogya World, Pennsylvania, United States of America
Sandeep Mittal Chandigarh State AIDS Control Society, Chandigarh, India
Poonam Bakshi Chandigarh State AIDS Control Society, Chandigarh, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20254423

Keywords:

HIV/AIDS, IDU, OST, Stigma, Time

Abstract

Background: The World Health Organization (WHO) defines substance abuse as the harmful or hazardous use of psychoactive substances, including alcohol and illicit drugs. Opioid substitution therapy (OST), which gradually and safely reduces an IDU’s opioid dependence. Several challenges at both structural and individual levels have arisen. Overcoming these hurdles is essential to fulfill the National AIDS Control Organization’s (NACO) mission to stop the spread of HIV. The present study aimed to identify the barriers to the OST program in Chandigarh and suggest strategies to overcome these challenges.

Methods: A community-based cross-sectional study was conducted among injecting drug users (IDUs) at the four OST centers in Chandigarh. The study employed a concurrent mixed-method approach.

Results: In this study, 81 respondents were surveyed, with 96.3% being male IDUs. The majority, 56.8%, were aged between 26 and 30 years, followed by 30.9% under 25 years. The most frequently injected drug was chitta (38.3%), followed by buprenorphine (9.9%), tapal (3.7%), and norphine (2.5%). With 66.7% of respondents indicated that time was an important and comfortable consideration to take OST. 65.4% of respondents indicated that the influence of OST influenced their decision to participate in the program. IDUs may leave OST follow-up if the dosage is inadequate to meet their needs. This can be a significant barrier to accessing OST.

Conclusions: This study underscored the necessity of a holistic approach to address the barriers to OST utilization among IDUs in Chandigarh. A comprehensive approach involving education, stigma reduction, increased treatment accessibility, and community involvement is crucial for enhancing the effectiveness of OST programs.

Metrics

Metrics Loading ...

References

United Nations Office on Drugs and Crime (UNODC). World Drug Report. Available at: https://www.unodc.org/unodc/data-and-analysis/ world-drug-report-2025.html. Accessed on 3 June 2025.

Census of India. Office of the Registrar General and Census Commissioner, India. 2011. Available at: https://censusindia.gov.in/census.website/en. Accessed on 3 June 2025.

Degenhardt L, Charlson F, Ferrari A, Santomauro D, Erskine H, Mantilla-Herrara A, et al. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatr. 2018;5(12):987-1012. DOI: https://doi.org/10.1016/S2215-0366(18)30337-7

Gomes T, Juurlink DN, Antoniou T, Mamdani MM, Paterson JM, Van den Brink W. Gabapentin. Opioids, and the risk of opioid-related death: a population-based nested case-control study. PLoS Med. 2018;15(1):e1002396. DOI: https://doi.org/10.1371/journal.pmed.1002396

Armstrong G, Humeniuk R, Ling W. The effectiveness of brief interventions for illicit drugs: a review of recent literature. Drug Alcohol Rev. 2016;35(4):345-54.

Davis JM, Garver-Apgar CE. Substance use and educational attainment: unpacking the relationships and setting the stage for targeted interventions. Curr Addict Rep. 2017;4:139-49.

Chaturvedi HK, Mahanta J, Bajpai RC, Pandey A. Correlates of injecting drug use among male IDUs and their female sex partners in north-eastern India. Drug and Alcohol Dependence 2014; 141: 20-26.

Jarlais D, Nugent DC, Solberg A, Feelemyer A, Mermin JJ, Holtzman D. Syringe service programs for persons who inject drugs in urban, suburban, and rural areas- United States, 2013. Morbid Mortal Week Rep. 2015;64(48):1337-41. DOI: https://doi.org/10.15585/mmwr.mm6448a3

Mathers BM, Degenhardt L, Bucello C, Lemon J, Wiessing L, Hickman M et al. Mortality among people who inject drugs: a systematic review and meta-analysis. Bull World Health Organ. 2010;91:102-23. DOI: https://doi.org/10.2471/BLT.12.108282

Cunningham CO, Sohler NL, Wong MD, Relf M, Barry D, Fortenberry JD, et al. Utilization of health care services in hard-to-reach marginalized HIV-infected individuals. AIDS Patient Care STDs. 2012;21(3):177-86.

Cunningham CO, Sohler NL, Wong MD, Relf M, Barry D, Fortenberry JD, et al. Utilization of health care services in hard-to-reach marginalized HIV-infected individuals. AIDS Patient Care STDs. 2012;21(3):177-86. DOI: https://doi.org/10.1089/apc.2006.103

Joseph H, Stancliff S, Langrod J. Methadone maintenance treatment (MMT): a review of historical and clinical issues. Mount Sinai J Med. 2010;67(5-6):347-64.

Kumar MS, Natale RD, Langkham B, Sharma M, Bolton R. Opioid substitution treatment in resource-poor settings. Bull World Health Organ. 2006;84(8):625-30.

Amato L, Davoli M, Perucci CA, Ferri M, Faggiano, Mattick RP. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J Subs Abuse Treat. 2005;28(4):321-9. DOI: https://doi.org/10.1016/j.jsat.2005.02.007

Yang LH, Wong LY, Grivel MM, Hasin DS. Stigma and substance use disorders: an international phenomenon. Curr Opin Psychiatr. 2017;30(5):378-88. DOI: https://doi.org/10.1097/YCO.0000000000000351

Latkin CA, Knowlton AR, Hoover D, Mandell W. Drug network characteristics as a predictor of cessation of drug use among adult injection drug users: a prospective study. Am J Public Health. 2014;89(3):347-50.

Barry CL, McGinty EE, Pescosolido BA, Goldman HH. Stigma, discrimination, treatment effectiveness, and policy: public views about drug addiction and mental illness. Psychiatr Serv. 2014;65(10):1269-72. DOI: https://doi.org/10.1176/appi.ps.201400140

Strang J, McCambridge J, Best D, Beswick T, Bearn J, Rees S, et al. Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow-up study. BMJ. 2013;326(7396):959-60. DOI: https://doi.org/10.1136/bmj.326.7396.959

Bruce RD, Schleifer RA. Ethical and human rights imperatives to ensure medication-assisted treatment for opioid dependence in prisons and pre-trial detention. Int J Drug Policy. 2013;24(1):e3-6.

Degenhardt L, Bucello C, Mathers B, Briegleb C, Ali H, Hickman M, et al. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction. 2011;106(1):32-51. DOI: https://doi.org/10.1111/j.1360-0443.2010.03140.x